Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma

Autor: Gimeno, Eva, Sánchez-González, Blanca, Álvarez-Larrán, Alberto, Pedro, Carmen, Abella, Eugenia, Comín, Josep, Saumell, Silvia, García-Pallarols, Francesc, Gómez, Miquel, Besses, Carles, Salar, Antonio
Zdroj: In Leukemia Research 2011 35(3):358-362
Databáze: ScienceDirect
Externí odkaz: